Rafael Molina

Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE

N. Viñolas, R. Marrades, J. Ramírez, 2008, Tumor Biology.

Use of serial carcinoembryonic antigen and CA 15.3 assays in detecting relapses in breast cancer patients

Martín Velasco, Nuria Giménez, Jaume Pahisa, 2004, Breast Cancer Research and Treatment.

Utility of serum tumor markers as an aid in the differential diagnosis of patients with clinical suspicion of cancer and in patients with cancer of unknown primary site

R. Molina, M. Solé, X. Bosch, 2012, Tumor Biology.

Evaluation of two strategies for the interpretation of tumour markers in pleural effusions

R. Molina, M. Doménech, Anna Arnau, 2017, Respiratory Research.

Usefulness of Serum Tumor Markers, Including Progastrin-Releasing Peptide, in Patients with Lung Cancer: Correlation with Histology

N. Viñolas, R. Marrades, J. Ramírez, 2009, Tumor Biology.